Articles
05.01.2022
Orphan Drugs and Diseases: 101

This article discusses updates to the orphan drugs and diseases landscapes, the challenges and incen...

Read more
Articles
20.12.2021
The end of higher drug prices in the US

In the US, an Act recently passed through the House of Representatives which plans to expand afforda...

Read more
Articles
15.12.2021
Patent protection in the pharmaceutical industry

Patent cliff refers to a sharp decline in revenue or profitability when a firm’s patents expire, o...

Read more
Articles
13.12.2021
Global market access team

This educational blog will explore what a GMA team does strategically and operationally across the l...

Read more
Articles
07.12.2021
What are the 5 Pricing & Market Access trends ...

Our experts provide an overview of the five key trends that could shape the pricing and market acces...

Read more
Articles
03.12.2021
Reflecting on the Pricing & Market Access tren...

Our experts reflect on the pricing and market access trends that shaped the European Landscape in 20...

Read more
Articles
22.11.2021
NICE cost effective medicines

When making a decision about the approval of a new product NICE (National Institute for Health and C...

Read more
Articles
17.11.2021
Head of agencies HAG

The Head of Agency Group (HAG) is a recently launched network created by the European Health Technol...

Read more
Articles
08.11.2021
High cost oncology combination therapy

The use of combination therapy is increasingly becoming the standard of care in oncology as cancers ...

Read more
Articles
03.11.2021
International Horizon Scanning Initiative

The IHSI is an independent legal entity, with representatives from eight member countries.

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.